DB04848ExperimentalSmall molecule
AZD0947 is a K+ channel opener, which was under investigation by AstraZeneca for the treatment of overactive bladder. As of March 2003, the drug was in phase II trials; however,... As of March 2003, the drug was in phase II trials; however, as of October 2004, it no longer appeared on the company’s development pipeline.
- Primary indication
- Intended for the treatment of urinary incontinence.Curator reviewed
- Code names
- AZD0947
Which companies are running trials of AZD0947, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account